characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak.
about
Zoonotic Poxviruses Associated with Companion AnimalsProteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination.Virulence in murine model shows the existence of two distinct populations of Brazilian Vaccinia virus strains.Early infections by myxoma virus of young rabbits (Oryctolagus cuniculus) protected by maternal antibodies activate their immune system and enhance herd immunity in wild populations.Occupational risks during a monkeypox outbreak, Wisconsin, 2003Novel Orthopoxvirus Infection in an Alaska Resident.A silent enzootic of an orthopoxvirus in Ghana, West Africa: evidence for multi-species involvement in the absence of widespread human diseaseSpectrum of infection and risk factors for human monkeypox, United States, 2003.Physiologic reference ranges for captive black-tailed prairie dogs (Cynomys ludovicianus).Evaluation of smallpox vaccines using variola neutralization.Serologic evidence of human orthopoxvirus infections in Sierra LeoneOcular vaccinia infection in laboratory worker, Philadelphia, 2004Human monkeypox outbreak caused by novel virus belonging to Congo Basin clade, Sudan, 2005.Optimization of peptide-based ELISA for serological diagnostics: a retrospective study of human monkeypox infectionComparison of Monkeypox Virus Clade Kinetics and Pathology within the Prairie Dog Animal Model Using a Serial Sacrifice Study DesignAnalysis of variola and vaccinia virus neutralization assays for smallpox vaccines.Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protectionHuman infection with a zoonotic orthopoxvirus in the country of Georgia.Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001.Humoral immunity to smallpox vaccines and monkeypox virus challenge: proteomic assessment and clinical correlations.Retrospective analysis of monkeypox infection.Nonhuman primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246.Monkeypox virus and insights into its immunomodulatory proteins.The smallpox vaccine induces an early neutralizing IgM response.Encephalitis after secondary smallpox vaccination.Detection and Molecular Characterization of Zoonotic Poxviruses Circulating in the Amazon Region of Colombia, 2014.From lesions to viral clones: biological and molecular diversity amongst autochthonous Brazilian vaccinia virus.Laboratory-acquired vaccinia virus infection in a recently immunized person--Massachusetts, 2013.Assessing Monkeypox Virus Prevalence in Small Mammals at the Human-Animal Interface in the Democratic Republic of the Congo.Transmission of atypical varicella-zoster virus infections involving palm and sole manifestations in an area with monkeypox endemicity.Severe eczema vaccinatum in a household contact of a smallpox vaccinee.NEW INVASIVE SPECIES IN SOUTHERN FLORIDA: GAMBIAN RAT (CRICETOMYS GAMBIANUS)
P2860
Q28646568-E9F18395-5B05-4756-9FF3-729D9A8D1C47Q30994031-4E9A65E7-8D7F-4655-B3B2-47EC328A0664Q33363146-8D1BDD7D-FE71-4FC2-BBD5-76F5EAEDCD87Q33585153-0DD9ABA3-7C41-4114-90DB-545D440AB000Q33686180-F605A7D6-5C20-4121-B040-EB6C281ED4A7Q33737080-4EA61EE2-DC19-49A5-93A6-00E62499570EQ33749647-F58B1DC3-67B6-46A4-B61F-02BF1887CF14Q33800871-A55EAEBD-04F3-461E-BCBF-E45EFF932C58Q33880074-57B0F5AD-FBCE-408A-968F-45D3FAAB5D87Q33920540-744CD59E-5E2C-44DB-9C90-49D591CFE6E1Q34060907-D9D2288E-272C-4595-81EF-2B4FC93B8983Q35793822-176F99B8-320D-4EC9-A03C-FAA29C4BBAB9Q35804572-7DF62268-78A1-4F94-B85A-675190C204D4Q35964833-D584751F-C896-459C-957A-F88574E60B44Q36032004-3BB15BE8-A8E4-4D21-B696-04C4E21CB19FQ36086257-25AA8A13-B9C3-432E-8A77-DB1495761557Q36313439-34F5CC82-71F7-46DF-834D-8B709E733809Q36407036-6DA8452A-235D-423B-BBC6-EC9ACEAFBF46Q36486818-1F1F3E0B-2837-40DD-8A59-F44189D617DFQ36559636-8CB699D8-EAF7-47DF-AE82-450749FF0284Q36944950-D5B053B8-04C7-4757-95C6-547DBBC1AB7EQ37204210-F61B06E2-8F67-4F66-848A-68C1DD7D44D5Q37287795-4764CF60-B52F-48A2-9749-0396BF91FBEEQ37456873-32EB3E54-9A72-44A8-88D5-2F1909826810Q37526751-E14D0808-6D64-4540-B7D9-3803632BC01FQ37722278-9295BD44-2093-40E7-8457-2DCEDAAF9641Q41198920-D3BA62EF-8D0A-4CA3-ABBD-5AE6485284FEQ41269913-57DC7274-714E-4673-A6BD-AB93849FF90BQ41925575-A41C9043-E51C-45E2-B4AE-6D32FCAE2E41Q45388494-ED1AA666-ACC6-472E-8333-12701C9EFF11Q46639360-86C63D33-C72F-437F-BE9E-EE381DB50065Q56781256-A60ECB28-C3F9-4C72-989F-1246CCA76264
P2860
characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
characterization of acute-phas ...... 2003 North American outbreak.
@ast
characterization of acute-phas ...... 2003 North American outbreak.
@en
type
label
characterization of acute-phas ...... 2003 North American outbreak.
@ast
characterization of acute-phas ...... 2003 North American outbreak.
@en
prefLabel
characterization of acute-phas ...... 2003 North American outbreak.
@ast
characterization of acute-phas ...... 2003 North American outbreak.
@en
P2093
P2860
P1476
characterization of acute-phas ...... 2003 North American outbreak.
@en
P2093
Inger K Damon
Joanne Patton
Kevin L Karem
Mary Reynolds
Nikeva Bernard
Zach Braden
P2860
P304
P356
10.1128/CDLI.12.7.867-872.2005
P577
2005-07-01T00:00:00Z